About Baum, Hedlund Aristei & Goldman
Baum, Hedlund, Aristei & Goldman, managed by senior partner Michael Baum, has the longest track-record handling SSRI (selective serotonin reuptake inhibitors) antidepressant litigation, having litigated more antidepressant cases in the past 20 years than any other law firm in the country.
Members of the firm have served as leaders on plaintiffs’ steering committees (PSC) that manage complex multi-district litigation arising from pharmaceutical and drug manufacturer negligence and currently serve on the PSC for the Heparin Products Liability Litigation and provide support to the PSCs for the Avandia mass tort litigation. Baum Hedlund also served as Lead Counsel for the Paxil Products Liability Litigation MDL, and as a member of the Fialuridine Product Liability MDL in Washington, D.C. and the Prozac Product Liability MDL out of Indianapolis.
Focusing a major part of its practice on drug product liability, the firm has represented victims of defective drugs since the late 1980s. Since 1990, Baum Hedlund has been handling SSRI antidepressant cases and served on the first SSRI-suicide litigation PSC in the early 1990s, involving Prozac, which was the first SSRI approved by the FDA for marketing in the U.S.
The firm has been litigating significant catastrophic personal injury and wrongful death product liability cases for over two decades, including airline and aircraft faulty parts and products, train and bus product failure, building construction flaws, and innumerable defective pharmaceutical product liability cases against defendants such as, Alpha Therapeutic, Armour Pharmaceutical Co., Baxter Health Care Corp, Bayer Corp, Ciba-Geigy, Covidien, Cutter Biologicals, Eli Lilly, Forest Labs, GlaxoSmithKline, Marion Merrell Dow/Richardson-Merrell, Merck, Oclassen, Pfizer, Schering-Plough, Sigma Aldrich, Solvay Pharmaceuticals and Wyeth.
In concert with Robinson Calcagnie Robinson Shapiro Davis, Inc, the firm has filed lawsuits and currently represents families of children from across the United States who have suffered PPHN and heart birth defects due to their mothers’ use of antidepressants during pregnancy.
Baum Hedlund has also filed Paxil suicide lawsuits across the country involving both children and adults including a nationwide class action involving false promotion of Paxil as safe and effective for children and adolescents. Attorneys Michael Baum and Nicole Maldonado are on the team handling our antidepressant birth defect and PPHN cases.
Past efforts by Baum Hedlund and others have resulted in improvements in drug safety including the FDA black box suicide warning issued on certain antidepressants. Thousands of clients from every state in the United States and six continents have been successfully represented by Baum Hedlund.
The firm has been on the prevailing side of some of the nation’s most highly-publicized cases. Such litigation involves complex evidence and choice of law issues which have been routinely handled by the firm in both state and federal courts. Many of Baum Hedlund’s attorneys have delivered Continuing Legal Education accredited lectures and written articles on the many complex issues involved in pharmaceutical litigation. Their attorneys have tried well over 200 cases in their careers.
Baum Hedlund has offices in Los Angeles, Philadelphia, and Washington, D.C., and is listed in the Bar Register of Preeminent Lawyers and is able to communicate in Spanish, German and Farsi.